{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:32:08Z","timestamp":1793817128990,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DK133694"],"award-info":[{"award-number":["DK133694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-025-01355-1","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:03:37Z","timestamp":1758877417000},"page":"2067-2082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A non-apoptotic caspase-8\u2013meteorin pathway in hepatocytes promotes MASH fibrosis"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-914X","authenticated-orcid":false,"given":"Xiaobo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary P.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanuza A. P.","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shareef","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Saleheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwayne G.","family":"Stupack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kisseleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Soto Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8653-1280","authenticated-orcid":false,"given":"Mitchell A.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3429-1515","authenticated-orcid":false,"given":"Ira","family":"Tabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"1355_CR1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","volume":"10","author":"A Wree","year":"2013","unstructured":"Wree, A., Broderick, L., Canbay, A., Hoffman, H. M. & Feldstein, A. E. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat. Rev. Gastroenterol. Hepatol. 10, 627\u2013636 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1355_CR2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537\u20132564 (2021).","journal-title":"Cell"},{"key":"1355_CR3","doi-asserted-by":"crossref","unstructured":"Younossi, Z. M., Kalligeros, M. & Henry, L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin. Mol. Hepatol. S32\u2013S50 (2024).","DOI":"10.3350\/cmh.2024.0431"},{"key":"1355_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo, P. et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389\u2013397 (2015).","journal-title":"Gastroenterology"},{"key":"1355_CR5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal, A. J. et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N. Engl. J. Med. 385, 1559\u20131569 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1355_CR6","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe, R. F., Tabas, I. & Pajvani, U. B. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology 158, 1913\u20131928 (2020).","journal-title":"Gastroenterology"},{"key":"1355_CR7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","volume":"15","author":"RF Schwabe","year":"2018","unstructured":"Schwabe, R. F. & Luedde, T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat. Rev. Gastroenterol. Hepatol. 15, 738\u2013752 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1355_CR8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"F Aguet","year":"2020","unstructured":"Aguet, F. et al. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"1355_CR9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41588-022-01078-z","volume":"54","author":"M Vujkovic","year":"2022","unstructured":"Vujkovic, M. et al. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation. Nat. Genet. 54, 761\u2013771 (2022).","journal-title":"Nat. Genet."},{"key":"1355_CR10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2019.11.024","volume":"72","author":"SA Harrison","year":"2020","unstructured":"Harrison, S. A. et al. A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis. J. Hepatol. 72, 816\u2013827 (2020).","journal-title":"J. Hepatol."},{"key":"1355_CR11","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/hep.26271","volume":"57","author":"M Hatting","year":"2013","unstructured":"Hatting, M. et al. Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents. Hepatology 57, 2189\u20132201 (2013).","journal-title":"Hepatology"},{"key":"1355_CR12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.15252\/emmm.201403856","volume":"6","author":"J Gautheron","year":"2014","unstructured":"Gautheron, J. et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol. Med. 6, 1062\u20131074 (2014).","journal-title":"EMBO Mol. Med."},{"key":"1355_CR13","doi-asserted-by":"publisher","unstructured":"Volkert, I. et al. Selective genetic inactivation of Caspase 8 in hepatocytes ameliorates progression of MASH following Jnk deficiency. Hepatology https:\/\/doi.org\/10.1097\/hep.0000000000001286 (2025).","DOI":"10.1097\/hep.0000000000001286"},{"key":"1355_CR14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","volume":"24","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab. 24, 848\u2013862 (2016).","journal-title":"Cell Metab."},{"key":"1355_CR15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adc9653","volume":"15","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis. Sci. Transl. Med. 15, eadc9653 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1355_CR16","doi-asserted-by":"crossref","first-page":"G174","DOI":"10.1152\/ajpgi.00041.2019","volume":"318","author":"G Wei","year":"2020","unstructured":"Wei, G. et al. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 318, G174\u2013G188 (2020).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1355_CR17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke, I. et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 4, 2823 (2013).","journal-title":"Nat. Commun."},{"key":"1355_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/bit.10473","volume":"81","author":"TM Sauerwald","year":"2003","unstructured":"Sauerwald, T. M., Oyler, G. A. & Betenbaugh, M. J. Study of caspase inhibitors for limiting death in mammalian cell culture. Biotechnol. Bioeng. 81, 329\u2013340 (2003).","journal-title":"Biotechnol. Bioeng."},{"key":"1355_CR19","doi-asserted-by":"crossref","first-page":"e7879","DOI":"10.1371\/journal.pone.0007879","volume":"4","author":"A Mielgo","year":"2009","unstructured":"Mielgo, A. et al. The death effector domains of caspase-8 induce terminal differentiation. PLoS ONE 4, e7879 (2009).","journal-title":"PLoS ONE"},{"key":"1355_CR20","doi-asserted-by":"crossref","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","volume":"288","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Transforming growth factor-beta (TGF-beta)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation. J. Biol. Chem. 288, 30708\u201330719 (2013).","journal-title":"J. Biol. Chem."},{"key":"1355_CR21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","volume":"143","author":"F Meng","year":"2012","unstructured":"Meng, F. et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143, 765\u2013776 (2012).","journal-title":"Gastroenterology"},{"key":"1355_CR22","volume":"5","author":"J Jiao","year":"2023","unstructured":"Jiao, J. et al. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease. JHEP Rep. 5, 100628 (2023).","journal-title":"JHEP Rep."},{"key":"1355_CR23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.abn3027","volume":"376","author":"MR Reboll","year":"2022","unstructured":"Reboll, M. R. et al. Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase. Science 376, 1343\u20131347 (2022).","journal-title":"Science"},{"key":"1355_CR24","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood.V97.11.3559","volume":"97","author":"ZQ Ning","year":"2001","unstructured":"Ning, Z. Q., Li, J. & Arceci, R. J. Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells. Blood 97, 3559\u20133567 (2001).","journal-title":"Blood"},{"key":"1355_CR25","volume":"40","author":"YW Dai","year":"2022","unstructured":"Dai, Y. W. et al. Meteorin links the bone marrow hypoxic state to hematopoietic stem\/progenitor cell mobilization. Cell Rep. 40, 111361 (2022).","journal-title":"Cell Rep."},{"key":"1355_CR26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/17425247.2025.2466767","volume":"22","author":"ZX Qin","year":"2025","unstructured":"Qin, Z. X. et al. GalNac\u2013siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases. Expert Opin. Drug Deliv. 22, 455\u2013469 (2025).","journal-title":"Expert Opin. Drug Deliv."},{"key":"1355_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","volume":"6","author":"CL Horn","year":"2022","unstructured":"Horn, C. L., Morales, A. L., Savard, C., Farrell, G. C. & Ioannou, G. N. Role of cholesterol-associated steatohepatitis in the development of NASH. Hepatol. Commun. 6, 12\u201335 (2022).","journal-title":"Hepatol. Commun."},{"key":"1355_CR28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","volume":"31","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Cholesterol stabilizes TAZ in hepatocytes to promote experimental non-alcoholic steatohepatitis. Cell Metab. 31, 969\u2013986 (2020).","journal-title":"Cell Metab."},{"key":"1355_CR29","doi-asserted-by":"crossref","first-page":"G747","DOI":"10.1152\/ajpgi.00024.2024","volume":"326","author":"G Kakiyama","year":"2024","unstructured":"Kakiyama, G. et al. StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 326, G747\u2013G761 (2024).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1355_CR30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/1440-1681.12241","volume":"41","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice. Clin. Exp. Pharm. Physiol. 41, 482\u2013488 (2014).","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"1355_CR31","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202305026","volume":"223","author":"B Deng","year":"2024","unstructured":"Deng, B. et al. TNF and IFNgamma-induced cell death requires IRF1 and ELAVL1 to promote CASP8 expression. J. Cell Biol. 223, e202305026 (2024).","journal-title":"J. Cell Biol."},{"key":"1355_CR32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/JLB.3MR0420-305R","volume":"109","author":"P Orning","year":"2021","unstructured":"Orning, P. & Lien, E. Multiple roles of caspase-8 in cell death, inflammation, and innate immunity. J. Leukoc. Biol. 109, 121\u2013141 (2021).","journal-title":"J. Leukoc. Biol."},{"key":"1355_CR33","volume":"8","author":"TCJ Verheul","year":"2020","unstructured":"Verheul, T. C. J., van Hijfte, L., Perenthaler, E. & Barakat, T. S. The why of YY1: mechanisms of transcriptional regulation by Yin Yang 1. Front. Cell Dev. Biol. 8, 592164 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1355_CR34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/gutjnl-2012-303150","volume":"63","author":"Y Lu","year":"2014","unstructured":"Lu, Y. et al. Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice. Gut 63, 170\u2013178 (2014).","journal-title":"Gut"},{"key":"1355_CR35","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/sj.emboj.7600202","volume":"23","author":"J Nishino","year":"2004","unstructured":"Nishino, J. et al. Meteorin: a secreted protein that regulates glial cell differentiation and promotes axonal extension. EMBO J. 23, 1998\u20132008 (2004).","journal-title":"EMBO J."},{"key":"1355_CR36","doi-asserted-by":"crossref","first-page":"e88811","DOI":"10.1371\/journal.pone.0088811","volume":"9","author":"YY Kim","year":"2014","unstructured":"Kim, Y. Y. et al. Meteorin regulates mesendoderm development by enhancing nodal expression. PLoS ONE 9, e88811 (2014).","journal-title":"PLoS ONE"},{"key":"1355_CR37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/glia.20600","volume":"56","author":"JA Park","year":"2008","unstructured":"Park, J. A. et al. Meteorin regulates angiogenesis at the gliovascular interface. Glia 56, 247\u2013258 (2008).","journal-title":"Glia"},{"key":"1355_CR38","doi-asserted-by":"crossref","DOI":"10.1080\/15476278.2023.2247576","volume":"19","author":"K Ortiz","year":"2023","unstructured":"Ortiz, K. et al. Human hepatocellular response in cholestatic liver diseases. Organogenesis 19, 2247576 (2023).","journal-title":"Organogenesis"},{"key":"1355_CR39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-0716-3207-9_13","volume":"2669","author":"X Liu","year":"2023","unstructured":"Liu, X., Brenner, D. A. & Kisseleva, T. Human hepatic stellate cells: isolation and characterization. Methods Mol. Biol. 2669, 221\u2013232 (2023).","journal-title":"Methods Mol. Biol."},{"key":"1355_CR40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/HEP.0000000000000933","volume":"81","author":"MP Moore","year":"2025","unstructured":"Moore, M. P. et al. Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation. Hepatology 81, 576\u2013590 (2025).","journal-title":"Hepatology"},{"key":"1355_CR41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"1355_CR42","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4, 1521 (2015).","journal-title":"F1000Res"},{"key":"1355_CR43","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1355_CR44","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","volume":"35","author":"A Zhu","year":"2019","unstructured":"Zhu, A., Ibrahim, J. G. & Love, M. I. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35, 2084\u20132092 (2019).","journal-title":"Bioinformatics"},{"key":"1355_CR45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","volume":"14","author":"J Reimand","year":"2019","unstructured":"Reimand, J. et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat. Protoc. 14, 482\u2013517 (2019).","journal-title":"Nat. Protoc."},{"key":"1355_CR46","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw171","volume":"2017","author":"AR Cortazar","year":"2017","unstructured":"Cortazar, A. R., Oguiza, J. A., Aransay, A. M. & Lav\u00edn, J. L. VerSeDa: vertebrate secretome database. Database 2017, baw171 (2017).","journal-title":"Database"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01355-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01355-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01355-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:51:44Z","timestamp":1761324704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01355-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1355"],"URL":"https:\/\/doi.org\/10.1038\/s42255-025-01355-1","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.W. and I.T., through Columbia University, have filed a provisional patent application related to the therapeutic implications of the findings in this study. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}